-
psnet.ahrq.gov/Information/Panel
January 01, 2012 - Leilani’s work has been discussed in The New York Times , The Wall Street Journal , and on CNN.com.
-
psnet.ahrq.gov/web-mm/hazards-distraction-ticking-all-ehr-boxes
April 09, 2014 - has a financial arrangement or other relationship with the manufacturers of any commercial products discussed
-
meps.ahrq.gov/data_files/publications/st498/stat498.shtml
February 01, 2017 - All comparisons discussed in the text are statistically significant at the .05 level 3 .
-
meps.ahrq.gov/data_files/publications/st396/stat396.shtml
January 01, 2013 - All differences between estimates discussed in the text are statistically significant at the 0.05 level
-
meps.ahrq.gov/data_files/publications/st425/stat425.pdf
November 01, 2013 - All differences between estimates discussed in the text are statistically
significant at the 0.05 level
-
meps.ahrq.gov/data_files/publications/st425/stat425.shtml
November 01, 2013 - All differences between estimates discussed in the text are statistically significant at the 0.05 level
-
psnet.ahrq.gov/web-mm/bad-writing-wrong-medication
March 01, 2015 - has no financial arrangements or other relationship with the manufacturers of any commercial products discussed
-
www.ahrq.gov/patient-safety/settings/hospital/candor/impguide.html
August 01, 2022 - Each module will also be discussed in its respective phase below.
-
psnet.ahrq.gov/web-mm/peripheral-iv-too-long
September 15, 2011 - has a financial arrangement nor other relationship with the manufacturers of any commercial products discussed
-
www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlas3.html
March 01, 2013 - The theoretical work that supports the framework is further discussed, as well as the rationale for how
-
www.ahrq.gov/ncepcr/research-transform-primary-care/transform/cost/report.html
October 01, 2015 - The incremental cost methodology is also discussed in Zuckerman et al. 23
Shi and colleagues then used
-
psnet.ahrq.gov/node/49702/psn-pdf
March 01, 2014 - relationship with the manufacturers of any
https://psnet.ahrq.gov//#references
commercial products discussed
-
psnet.ahrq.gov/primer/retained-surgical-items-definition-and-epidemiology
September 15, 2024 - Therefore, careful examination of what RSI are being discussed in RSI estimates is warranted.
-
meps.ahrq.gov/data_files/publications/st439/stat439.shtml
May 01, 2014 - All differences between estimates discussed in the text are statistically significant at the 0.05 level
-
meps.ahrq.gov/data_files/publications/st364/stat364.shtml
March 01, 2012 - Only differences that are statistically significant at the 0.05 level are discussed in the text.
-
psnet.ahrq.gov/perspective/communication-during-transitions-care
July 10, 2024 - This essay showcases these articles, which discussed strategies for healthcare professionals and organizations
-
meps.ahrq.gov/data_files/publications/st282/stat282.shtml
April 01, 2010 - Unless otherwise indicated, all differences discussed in the text are statistically significant at the
-
meps.ahrq.gov/data_files/publications/st550/stat550.shtml
September 01, 2023 - Only differences between statistically significant estimates at the 0.05 level are discussed in the text
-
psnet.ahrq.gov/web-mm/safety-and-quality-long-term-care
January 01, 2016 - have a financial arrangement or other relationship with the manufacturers of any commercial products discussed
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/091-decolonization-implementation-fg.docx
April 01, 2025 - Slide 13
Cardiac Case Example—2
SAY:
Efforts to improve patient compliance for mupirocin were discussed